Platelet BioGenesis is developing technology to produce the world’s first donor-independent human platelets from human induced pluripotent stem cells. This technology will bridge the gap from megakaryocyte to platelet. Platelets are the ‘bandaids’ of the bloodstream, responsible for clot formation and blood vessel repair. Over 2 million Americans receive platelet transfusions annually that dramatically increase survival rates for cancer, transplant, and surgery patients.

We provide shared lab and office space to life science and biotech startups. Learn more about us here.

Contact Us 

(617) 245-8548

325 Vassar St. 

Cambridge, MA 02139

Our Services

Quick Links

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram